Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P25
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-25.19%
2024-100.52%
202315297.57%
20220.00%
20210.00%